| Day of treatment | Days after treatment | ||||||||||||
| Groups (n = 6) | Sex | Weight | Dose | 0 | 7 | 14 | 21 | 28 | |||||
| (ml) | Tox* | Anc** | Tox | Anc | Tox | Anc | Tox | Anc | Tox | Anc | |||
| M | 10 | 1 | 50 | 600 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 1 | M | 6 | 0.6 | 150 | 300 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ivermectin 0.5% | M | 4 | 0.4 | 650 | 1350 | 0 | 0 | 150 | 0 | 50 | 0 | 0 | 100 |
| F | 8 | 0.8 | 100 | 250 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| F | 4 | 0.4 | 350 | 800 | 0 | 0 | 200 | 0 | 0 | 0 | 0 | 0 | |
| F | 6 | 0.6 | 150 | 200 | 0 | 0 | 200 | 150 | 0 | 300 | 0 | 250 | |
| Total of EPGF/group | 1450 | 3500 | 0 | 0 | 550 | 150 | 50 | 300 | 0 | 350 | |||
| F | 5 | 0.5 | 250 | 10,250 | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 2 | F | 8 | 0.8 | 100 | 150 | 150 | 1500 | 100 | 1750 | 50 | 1150 | 50 | 800 |
| Ivermectin 0.2% | M | 4 | 0.4 | 150 | 650 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 0 |
| M | 6 | 0.6 | 300 | 1750 | 0 | 900 | 0 | 650 | 0 | 2150 | 0 | 1650 | |
| F | 15 | 1.5 | 100 | 4450 | 150 | 29,100 | 0 | 8050 | 0 | 17,350 | 0 | 14,900 | |
| M | 6 | 0.6 | 100 | 3500 | 100 | 1000 | 0 | 700 | 0 | 150 | 0 | 100 | |
| Total of EPGF/group | 1000 | 20,750 | 450 | 32,600 | 100 | 11,150 | 50 | 20,800 | 50 | 17,450 | |||
| F | 4 | --- | 750 | 750 | 0 | 0 | 100 | 4350 | 0 | 1750 | 0 | 2400 | |
| 3 | M | 7 | --- | 100 | 550 | 50 | 0 | 200 | 50 | 150 | 500 | 0 | 9400 |
| Untreated | M | 11 | --- | 100 | 800 | 250 | 50 | 850 | 100 | 50 | 3400 | 0 | 7100 |
| Control | F | 3 | --- | 3500 | 9700 | 2400 | 350 | 50 | 3000 | 0 | 8100 | 0 | 1450 |
| M | 9 | --- | 350 | 350 | 2400 | 50 | 5050 | 50 | 5050 | 0 | 0 | 1750 | |
| F | 11 | --- | 100 | 750 | 50 | 0 | 100 | 50 | 250 | 500 | 50 | 3600 | |
| Total of EPGF/group | 4900 | 12,900 | 5150 | 450 | 6350 | 7600 | 5500 | 14,250 | 50 | 25,700 | |||